Andrew Weickhardt

8.6k citations
115 papers · 3.4k · 2 hit papers · h-index 24

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Prostate Cancer Treatment and Research

Papers in

    • Prostate Cancer Treatment and Research 26
    • Lung Cancer Treatments and Mutations 19
    • Renal cell carcinoma treatment 11
    • Cancer Immunotherapy and Biomarkers 20
    • Colorectal Cancer Treatments and Studies 18
    • CAR-T cell therapy research 9

Andrew Weickhardt

107 papers receiving 3.4k citations

Andrew Weickhardt's Hit Papers

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer 2012 · 823 citations
8230+4+9Years since publication250500750

Peers

Andrew Weickhardt
Comparison fields: 5 of 80
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 2.1k
  • Cancer Research 405
  • Pathology and Forensic Medicine 285
  • Hepatology 113
Replace Venice Archer with:
Venice Archer United Kingdom
Hong‐Hong Yan China
V.A. Miller United States
Jin‐Ji Yang China
Oleg Gladkov Russia
Bilal Piperdi United States
Davey B. Daniel United States
Mircea Dediu Romania
Anh T. Le United States
Marine Gross‐Goupil France
Andrew Weickhardt relative to Venice Archer United Kingdom Venice Archer's profile →
Citations per field
00.5×1.5×2.1×
Venice Archer · 1×
Citations per year

Countries citing papers authored by Andrew Weickhardt

Since Specialization
Citations

This map shows the geographic impact of Andrew Weickhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Weickhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Weickhardt more than expected).

Fields of papers citing papers by Andrew Weickhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Weickhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Weickhardt. The network helps show where Andrew Weickhardt may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Weickhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Weickhardt Line = papers co-authored together Andrew Weickhardt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Hit paper breakdown →
2012823
2
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
Hit paper breakdown →
2012514
3 2012225
4 2011170
5 2014169
6 201390
7 201284
8 201270
9 201866
10 201262
11 201862
12 201861
13 201154
14 201548
15 201146
16 201346
17 201246
18 202044
19 201339
20 201533

About Andrew Weickhardt

Andrew Weickhardt is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 115 papers that have together received 3.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (18 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Renal cell carcinoma treatment (11 papers), Bladder and Urothelial Cancer Treatments (11 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (2.1k citations), Cancer Research (405 citations), Pathology and Forensic Medicine (285 citations) and Hepatology (113 citations). Andrew Weickhardt has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include D. Ross Camidge, Robert C. Doebele, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Anh T. Le, Xian Lu, Gregory N. Gan, Laurie E. Gaspar and Benjamin Scheier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, European Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact